The genetic modules that contribute to human evolution are poorly understood. We identified positive selection for two independent involucrin (IVL) haplotypes in European (CEU) and Asian (JPT/CHB) populations for skin epidermis. CEU IVL associated with increased IVL and a known epidermal-specific enhancer underwent a recent selective sweep out-of-Africa correlating with increased northern latitude. CRISPR/Cas9 deletion of the mouse enhancer revealed enhancermediated cis regulation for Ivl expression with human population-specific enhancer reporter assays confirming the additive effect. Furthermore, IVL enhancer eQTLs associated with decreased IVL together with filaggrin loss-of-function variants are enriched in atopic dermatitis cases vs. controls. Together, our enhancer-IVL cis regulatory module findings reveal an emerging paradigm for recently evolved traits to impact skin disease risk in contemporary populations.
INTRODUCTION
Modern humans (Homo sapiens) have evolved by adapting to local environments and niches, under constant pressure to provide a fitness advantage for survival 1 . Our current understanding of human evolution has been founded on observable phenotypic changes and the underlying genetic variation. However, whole genome sequencing and downstream methodology have facilitated a more reverse genomics approach, allowing researchers to more accurately pinpoint significant genetic differences and thus reveal additional adaptive traits 2, 3 . In particular, the availability of multiple divergent human genomes has revolutionized the field, enabling the identification of loci undergoing selection in different populations and their impact on human health 3, 4 . Here we investigate human skin barrier adaptation by examining evolution of the Epidermal Differentiation Complex (EDC) locus. The EDC (located at human Chr1q21, Chr3q in mice) exhibited the highest rate of non-synonymous substitutions in the human genome and was ranked as the most rapidly diverging gene cluster in the human-chimp genome comparison 5 . The EDC spans approximately 1.6 Mb and contains 64 genes representing four gene families, including the Filaggrin (FLG)-like or SFTP (S100 fused type protein), Late Cornified Envelope (LCE), Small Proline Repeat-Rich (SPRR), and S100-domain (S100) family members 6, 7 . The expression of many of these EDC genes is a hallmark feature of the terminally differentiated epidermal cells (keratinocytes) that comprise the interfollicular epidermis at the skin surface 8 . Many EDC proteins, including involucrin (IVL) and many SPRRs and LCEs, are covalently cross-linked to form the cornified envelope that surrounds the keratinocyte 8 . Identification of EDC orthologs across many mammalian genomes [9] [10] [11] [12] led to the discovery of the observed linearity and synteny of the EDC in both mammals and vertebrates 6, 7, [13] [14] [15] [16] [17] . We previously identified positive selection in the EDC for specific genes across the mammalian phylogeny, and even specifically in primates and humans 18 . Motivated by these studies, we hypothesized ongoing evolution within the EDC for skin barrier adaptation among the geographically diverse group of modern-day human populations.
RESULTS

Population-specific signals of positive selection in the Epidermal Differentiation Complex reveal recent human evolution in the skin barrier with a convergence at involucrin (IVL)
We identified positive selection in the EDC using 2 independent algorithms, Composite of Multiple Signals (CMS) 19, 20 and the integrated Selection of Allele Favored by Evolution (iSAFE) 21 (Fig. 1 populations. We extracted CMS scores for each EDC SNP from each population. Positive selection was only found near LCE3E in YRI, as evidenced by a cluster of three SNPs with CMS scores > 0 ( Fig. 1b , Table S1 ). In contrast, we identified three clusters of positive CMS-scoring SNPs in JPT/CHB in the regions of HRNR-FLG, CRNN-LCE5A, and IVL-LINC01527. The HRNR-FLG genomic region exhibited the strongest signal of positive selection for this combined population (0.63≤CMS≤5.23) and is in linkage disequilibrium (LD) (r 2 ≥ 0.8) with a previously reported positively selected HRNR-FLG "Huxian haplogroup" in the Han Chinese population 22 .
CEU harbored four genomic regions with evidence of positive selection: LCE2D-LCE2C, SMCP-IVL, SPRR2E-SPRR2F, and S100A6. The signal of selection at SMCP(3.18≤CMS≤8.17) was the strongest signal in CEU and of any population. As SMCP encodes a sperm mitochondrial cysteine-rich protein 23 , the finding suggests a role for the positively selected SNPs in sperm function. Importantly, IVL was the only gene with evidence of positive selection observed in both JPT/CHB and CEU populations. However, the positively selected SNPs in the IVL region were distinct between the two populations (Table S1 ). Together, our results identify multiple population specific signals of positive selection, with a notable convergence of distinct positive selection at IVL in two geographically distinct human populations.
We sought to validate and refine the positively selected regions identified by CMS using iSAFE. iSAFE scores were calculated for 1000 Genomes Project (1KGP) Phase 3 SNPs within the EDC in YRI, JPT/CHB, and CEU populations 21 , with evidence of positive selection defined as a peak height greater than 0.1. We found no evidence of positively selected SNPs using iSAFE in YRI. iSAFE revealed positive selection at LCE1F-LCE1B in JPT/CHB that was not identified by CMS ( Fig. 1c , Table S2 ), and did not replicate the CMS findings for HRNR-FLG and CRNN-LCE5A (Fig. 1b) . A weak iSAFE peak (peak height .076) between SMCP and IVL was observed in JPT/CHB but was just below the 0.1 threshold for positive selection. In CEU, iSAFE identified three genomic regions under positive selection that included HRNR-CRNN, LCE2D, and LCE1B-SPRR5 ( Fig. 1c , Table S3 ). The HRNR-CRNN signal includes multiple genes in the S100-fused family (HRNR, FLG, FLG2, CRNN genes), and the noncoding RNA FLG-AS1. Interestingly, neither the HRNR-CRNN peak nor the peak at LCE2D was identified by CMS. The LCE1B-SPPR5 iSAFE peak region includes the genes LCE1B, LCE1A, LCE6A, SMCP, IVL, LINC01527, and SPRR5. Strikingly, the LCE1B-SPRR5 iSAFE peak includes 12 of the 13 SNPs identified by CMS in CEU, further validating positive selection associated with these SNPs. Together, our results identify positive selection at the SMCP-IVL loci for both CEU and JPT/CHB using CMS with independent validation for CEU by iSAFE, solidifying the significance of this region for human skin barrier evolution.
We next determined the haplotypes for the positively selected SNPs in the SMCP-IVL regions in JPT/CHB and CEU. We identified that positively selected JPT/CHB SMCP-IVL and CEU-IVL haplotypes overlap at IVL and represent independent yet shared emergences of positive selection at this locus. Specifically, linkage analysis for the high-CMS SNPs rs6668295 and rs11205130 (r 2 =1.0) revealed a SMCP-IVL haplotype (46.5 kb) in JPT/CHB that spans from the SMCP promoter to 3' of IVL ( Fig. 2a , Table S1 ). A second, neighboring JPT/CHB-LINC01527 haplotype (23.0 kb; rs78730108 and rs4240864, r 2 =1.0) is named for and contains a skin-specific long intergenic non-coding RNA 24 . In CEU, eight high-CMS SNPs comprise a distinct CEU-IVL haplotype (41.2 kb) that spans from 3' of SMCP to 3' of IVL (0.8146<r 2 <1.0). A neighboring CEU LCE1A-SMCP haplotype (65.2 kb) contains four of the five high-CMS SNPs in the region (r 2 =1.0). Notably, the SNPs that comprise the CEU high-iSAFE LCE1B-SPRR5 peak belong to the two haplotypes defined by the high-CMS SNPs in the region. Together, this analysis identified a convergence of positive selection around IVL.
Notably, the positively selected CEU-IVL haplotype is globally distributed, with the haplotype found in European (AF=0.86), African (AF=0.27), East Asian (AF=0.42), South Asian (AF=0.68), and admixed American (AF=0.67) populations. This suggests that the origin of the CEU-IVL haplotype minimally dates prior to the migration out of Africa. We next examined the correlation between the allele frequency for the CEU-IVL haplotype proxy SNP, rs4845327-G, for a given 1KGP population with respect to the population's latitude. We find a direct and positive correlation between the G allele of rs4845327 and northern latitude (R 2 = 0.95, ρ = 0.88, Fig. 2b ). Together, these data reveal a recent selective sweep for the CEU-IVL haplotype in European populations at increasingly Northern latitudes.
CEU-IVL haplotype is associated with increased IVL gene expression and JPT/CHB
SMCP-IVL haplotype is associated with decreased IVL gene expression
We next determined the functional significances of the positively selected CEU-IVL and JPT/CHB SMCP-IVL haplotypes using Genotype-Tissue Expression Project (GTEx) 25 . The CEU-IVL haplotype contains expression quantitative trait loci (eQTLs) associated with increased IVL expression ( Fig. 2c , top; representative SNP rs4845327 shown), while the JPT/CHB SMCP-IVL haplotype harbors eQTLs associated with decreased IVL expression ( Fig. 2c , representative SNP rs1974141 shown). We hypothesize that this differential expression is driven by an enhancer with population-specific variation. We previously identified and characterized a strong epidermal-specific enhancer located upstream of IVL 7 (Fig. 2a, Fig. 3a ). This enhancer, termed '923,' is located 923 kb from the most 5' EDC gene and is associated with the dynamic chromatin remodeling of the EDC and cJun/AP1 binding concomitant with EDC gene expression 26 . Both the CEU-IVL and JPT/CHB SMCP-IVL haplotypes contain the 923 enhancer and IVL. This led us to hypothesize that the 923 enhancer modulates IVL expression associated with positive selection.
Deletion of the 923 enhancer in mice results in decreased expression of the proximal gene involucrin in the skin
To determine the function of the 923 enhancer, we generated knockout mice for the orthologous 923 enhancer using CRISPR/Cas9 genome editing ( Fig. 3a ). Two independent deletions were successfully generated, resulting in a specific deletion of the 923 enhancer (923 del ) and a large 40kb deletion that included the 923 enhancer and proximal genes Smcp and 2210017I01Rik (923 large ) ( Fig. 3b , Table S4 , Fig. S1 ). 923 del and 923 large knockout mice were viable at birth and did not deviate from the expected genotype ratios for both heterozygous parental crosses (Χ 2 test, α =0.05) (Table S5 ). We next examined the molecular impact of the 923 enhancer deletion on the skin transcriptome. RNA-seq on 923 del and 923 large homozygous, heterozygous, and wild-type (WT) newborn skins was performed (Table S6- 9) . Given the close proximity of the 923 enhancer to involucrin (Ivl), we included the Ivl knockout mouse 4 in our analyses to distinguish the direct effect of the loss of the enhancer from the hypothesized loss of involucrin (Table S10 ). Analysis of the skin transcriptomes identified 6 significantly differentially expressed genes (DEGs) in 923 del/del skins, in contrast to 157 and 222 genes in 923 large/large and Ivl -/skins, respectively (FDR < 0.05, log2(FC)>|2|) ( Fig. 3cd ). Strikingly, 5 of the 6 DEGs in 923 del/del (Rps3a3, Hist1h2aI, Gm16011, Rsp3a1, and Ivl) were also differentially expressed in the same directions in 923 large/large skins ( Fig. 3d, Fig. S2 ). Gm15264 was only differentially expressed in 923 del/del mice. As Rps3a1, Rps3a3, Hist1h2aI, and Gm16011 were also differentially expressed in the same directions in Ivl -/skins, their observed differential expression in the 923 deletion lines are likely secondary effects associated with decreased Ivl expression in the two enhancer deletion skins. Together, our in vivo results identify a functional role for the 923 enhancer in the regulation of Ivl target gene expression.
The effect of the enhancer deletion on the expression of its most proximal gene, Ivl, motivated us to further examine local transcriptional effects with respect to only the EDC. RNAseq analyses of the EDC loci identified one DEG (Ivl) in 923 del/del ,10 in 923 large/large , and 10 in Ivl -/skin ( Fig. 3ef ) (FDR < 0.05, log2(FC)>|2|). Smcp, the most proximal gene 3' of 923 ( Fig. 3b ), was below our detection limits for this assay, consistent with the low numbers of transcripts detected in whole skin scRNA-seq 27 . We validated the significance of decreased Ivl expression in all 3 mouse lines via qPCR (ANOVA; Tukey post-hoc P<0.05) ( Fig. 3g ). By contrast, 923 large/large mouse skins also exhibited significantly decreased expression of Lce6a, the most proximal gene 3' of the deletion, that was not observed in the other 2 mouse lines. This suggests the presence of an additional as yet uncharacterized enhancer region for Lce6a that was also deleted in the 923 large allele. Together, both enhancer deletion lines demonstrate a requirement for the enhancer to positively regulate Ivl expression and for the 923 large allele for Lce6a expression.
enhancer regulates Ivl target gene expression in an allele-specific (cis) manner
To determine if the 923 enhancer regulates gene expression in cis, we assessed allele- However, a significantly lower proportion of B6 SNPs (3%) for Lce6a was observed only in the 923 large B6/BALB heterozygous mice compared to 42% observed in the control B6/BALB WT skins (ANOVA, Tukey post-hoc, P<0.01). This further supports the hypothesis of the loss of a regulatory enhancer in the 923 large allele that regulates allele-specific Lce6a expression.
Together, our genetic findings identify cis regulation by the 923 enhancer for Ivl and additionally for Lce6a by the 923 large allele.
Deletion of 923 enhancer affects the chromatin landscape in the EDC
We next sought to determine the effect of the 923 enhancer deletion on the EDC chromatin landscape. Open (or accessible) chromatin in the epidermis of newborn 923 del/del , 923 large/large , and WT mice was determined using ATAC-seq (assay for transposase accessible chromatin using sequencing) 28 . A total of 383,971 accessible chromatin regions were identified genomewide. We next determined differential chromatin accessibility between WT and 923 del/del and also 923 large/large epidermis. Ten differentially accessible regions (DARs) were identified between 923 del/del and WT mice in contrast to 23 DARs found in the 923 large/large comparison (Fig. 4a , Table   S11 -12) (FDR<0.05, log2(FC)>|2|). Six of these DARs were shared between the 923 del/del and 923 large/large comparisons ( Fig. 4a ), including two peaks on chromosome X and four peaks on chromosome 3, three of which are within or near (<250kb) the EDC (Fig. 4b, Fig. S3 ). Two DARs, intergenic to Lce3e/Lce3f and corresponding with pseudogene Gm29950 (intergenic to S100a11/S100a10), were less accessible whereas an intergenic DAR at Tdpoz4/Tdpoz3 was more accessible in both 923 del/del and 923 large/large skins compared to WT. Although none of the DAR proximal genes were significantly differentially expressed in 923 del/del skin, 3 of the 23 923 large/large DARs correlated with significant changes in 4 genes in 923 large/large mice, all located within the EDC (Ivl, 2210017l01Rik, Lce3e, Lce3f) (FDR <0.05). (Fig. S4 ). Thus, we determine that deletion of the 923 enhancer results in less accessible chromatin in the EDC and highlights a functional role to facilitate proximal chromatin accessibility.
The human 923 sequence enhances expression from the IVL promoter and both elements exhibit population-specific regulatory activities
Our discoveries for the positively selected IVL human haplotypes associated with differential IVL expressions and the 923 enhancer:Ivl module in mice led us to investigate the functionality of human population-specific alleles for the 923 enhancer:IVL module. We tested population-specific alleles containing the IVL promoter, first (noncoding) exon, and intron, which are known to exhibit collective regulatory activity 29 (Fig. 5a ). The CEU IVL promoter/intron allele exhibited significantly higher luciferase activity than the JPT/CHB and YRI alleles in both proliferating and differentiated keratinocyte cell culturing conditions (P<0.05), consistent with the GTEx annotation for increased IVL expression ( Fig. 5b, Fig. 2c ). We next added the respective population-specific enhancer to its IVL promoter/intron allele and found further increased luciferase reporter activities for all population-specific alleles compared to the promoter/intron only alleles, and specifically more so in differentiated cells, where IVL is endogenously expressed in skin tissue. However, a comparison between population-specific alleles revealed relatively decreased luciferase activity for the JPT/CHB enhancer/promoter/intron allele compared to CEU and YRI alleles, again consistent with the relatively decreased IVL expression associated with this haplotype in GTEx (Fig. 5b, Fig. 2c ). Thus, our findings further support the cis-regulation of human IVL by the enhancer, with the CEU enhancer/IVL promoter/intron allele driving increased IVL expression and conversely decreased expression in the JPT/CHB allele, both of which we show are under positive selection (Fig. 1) .
IVL eQTLs in the 923 enhancer are a modifier for FLG LOF-associated AD
The impact of the 923 enhancer variation on IVL expression in human evolution led us to examine a potential role for the 923 enhancer variation in skin disease. Atopic dermatitis (AD) is a common inflammatory skin disease with skin barrier deficiency as a major etiological factor, as evidenced by the discoveries for more than 100 pathogenic loss-of-function (LOF) variants in the filaggrin (FLG) gene [30] [31] [32] . The observation that not all FLG LOF heterozygotes are diagnosed with AD supports a hypothesis of incomplete penetrance and suggests additional modifiers for the disease. We hypothesized that 923 enhancer variation, and resulting decreased IVL expression, impact FLG LOF-associated AD. Targeted sequencing of FLG and the 923 enhancer were independently performed in subjects with moderate to severe AD (n=110) and healthy controls (n=30) [33] [34] [35] [36] [37] . Individuals from GTEx with whole genome sequencing data (n=642) 25 were included as additional controls and variants were identified through filtering of vcf files.
Targeted sequencing of the 923 enhancer region in AD cases identified 30 variants (Table S13 ). Three were unique to cases (rs1344252044, rs139775257, and rs76513010) and strikingly, seven of the 30 variants are IVL eQTLs associated with decreased IVL expression in skin and correspond with two different haplotypes, CEU minor and JPT/CHB ( Fig. 5a-b , Table   S14 ). In fact, a ranked list of effect sizes for genes with eQTLs within the EDC revealed IVL as the gene exhibiting the largest range of effect sizes for decreased expression (Table S15) . IVL was the only gene to harbor eQTLs that all had negative effect sizes which correlates with the CEU haplotype being associated with increased IVL expression (171 eQTLs; -0.16 to -1.00) (adjusted P < 0.05) (GTEx V7, Tables S14). Through sample allele phasing and imputation, we established that 77% of the 30 alleles present in the AD cases harbored at least one IVL eQTL (n=22) (Fig. S6 ). Luciferase assays for single variant alleles revealed no differences in four discovered variants (rs186688062-A, rs77106372-A, rs115251823-T, and rs1854780-A minor alleles); however, the rs78868757-A variant exhibited significantly decreased enhancer activity compared to the major allele in both proliferating and differentiated keratinocytes (~2-fold; proliferating [P < 0.01]; differentiated [P < 6.4 X 10 -5 ]) ( Fig. 5c ). We next examined the impact of the IVL eQTLs in AD subjects in both nonlesional and lesional skin areas. AD cases with IVL eQTLs exhibited a trend toward decreased IVL expression in lesional skin and significantly decreased expression in nonlesional skin (P < 0.14 and 0.04, respectively) ( Fig. 5d ). As a result, IVL immunohistochemical staining was markedly decreased in the patients' nonlesional skin in comparison to non-IVL eQTL skin (Fig. 5e ). Our results for IVL eQTLs and the uncommon rs78868757 923 enhancer variant associated with decreased IVL gene and protein expression highlight the functional impact of these enhancer variants on diseased skin.
Significant enrichment of IVL eQTLs and FLG LOF variants in atopic dermatitis patients
We evaluated the impact of having at least one IVL eQTL and at least one FLG LOF variant on AD outcome. FLG LOF variants were enriched in AD cases compared to controls, but did not reach significance (P < 0.06). The proportion of AD patients with at least one IVL eQTL was 42% (n=47) and significantly enriched compared to healthy and GTEx controls (24%; P< 0.0001) ( Fig. 5f ). Among the controls, only 3.7% (n=25) genotyped for both an IVL eQTL and a FLG LOF variant (Fig. 5f ). By contrast, this genetic combination was significantly enriched in AD patients at 10.0% (n=11; P < 0.0109). An analysis of the effect of this genetic combination on disease severity was inconclusive given the small number of patients with SCORAD data in our cohort (data not shown). Nevertheless, our data identifies a significant enrichment of IVL eQTLs in the presence of FLG LOF variants, thus identifying IVL eQTLs and FLG LOF variants as potential modifiers for the skin barrier in AD pathogenesis.
DISCUSSION
Our work thus far has identified recent skin barrier evolution in modern human populations, having discovered multiple population-specific signals of positive selection within the EDC and selection in two independent yet convergent haplotypes for IVL. The associations of CEU-and JPT/CHB-specific haplotypes with relatively increased and decreased IVL gene expression, respectively, and their overlap to the known epidermal-specific enhancer 923 led us to examine a functional role for the 923 enhancer to regulate Ivl expression in vivo. Deletion of the orthologous mouse 923 enhancer via CRISPR/Cas9 editing identified Ivl as the primary target gene of 923 with regulation in cis, thus establishing a 923 enhancer-Ivl gene regulatory module.
The functional significance of this genetic module in humans was further revealed with our discoveries of population-specific 923 enhancers that "boosted" regulatory activity and with the observation that IVL eQTLs are enriched in atopic dermatitis patients with FLGLOF variants.
Together, we establish the significance of a paradigmatic regulatory module for a cis-regulatory enhancer/target gene in both human evolution and disease.
Our understanding of the molecular mechanisms that drive enhancer activity 38, 39 and the comprehensive genomic elucidation of putative enhancers for a vast array of tissue types, as well as single cells, has exponentially grown since the inception of the "enhancer" concept in 1981 40 . Yet we are challenged to embark on more rigorous investigations to functionally validate enhancers and correctly assign their predicted target genes 39 . Even more challenging is the growing body of recent reports demonstrating a lack of phenotypes for enhancer deletions, even for putative developmental enhancers, suggesting enhancer redundancy consistent with the ENCODE findings of 2-3 enhancers per target gene [41] [42] [43] . As Ivl expression was not completely lost in our enhancer knockout mice, there is likely redundancy in regulation of Ivl yet we have firmly established the 923 enhancer as a prominent proximal enhancer. 5C studies in keratinocytes identified physical interactions between the Ivl promoter and enhancers located in the first topologically associated domain (TAD) of the EDC, presenting additional putative regulators 44 . Our discovery for the 923 enhancer regulation of Ivl expression was premised on extensive previous analyses 7, 26 and offers a framework to prioritize such ongoing and future enhancer in vivo deletion studies. Furthermore, our CRISPR/Cas9 methodology led to the serendipitous generation of a larger deletion (923 large ), which displayed decreased Lce6a expression that generates the hypothesis for additional enhancers that were deleted in the 14 Another interesting finding is the effect on DARs due to loss of 923 enhancer. DARs that were enriched within the EDC were less accessible upon deletion of 923, minimally suggesting a direct role for the enhancer in governing physical chromatin accessibility within the EDC. The shared EDC DARs are also located in different TADs than 923, supporting inter-TAD interactions as previously described 44 . The mechanism of chromatin accessibility regulation by 923 remains elusive, however, no physical interactions were identified between 923 and these DARs in previous 3C and 5C analysis of the EDC 26, 44 . Also of note, one of the shared DARs almost completely overlaps the pseudogene Gm29950 that was not detected in our whole skin RNA-seq data set for 923 del/del , 923 large/large , Ivl -/and WT keratinocytes but warrants further higher resolution investigation in this region. It is also interesting that we did not identify the 923 enhancer as an accessible region in wild-type cells. We hypothesize the dense occupation of transcription factors at this active enhancer biases against transposase insertion needed for ATAC-seq, resulting in the interpretation of 'closed' chromatin at the focused region yet enrichment at the flanking sites, a hypothesis that should be considered when using chromatin accessibility as a genome-wide predictor of enhancers. Overall, our ATAC-seq illustrates a role for the 923 enhancer in governing local chromatin accessibility.
Interestingly, the backbone of the CEU-IVL haplotype appears to have emerged in Africa and rose to high frequency in CEU. This recent selective sweep for CEU-IVL is associated with increased IVL expression, which we tied to the promoter/intron variants. The promoter SNP rs1854779 is a strong candidate for the causal variant, as it is predicted to generate a gain-offunction NFI transcription factor binding site that could increase transcription. By contrast, the positively selected JPT/CHB enhancer/promoter/intron allele exhibited relatively decreased reporter activity and contains unique polymorphisms in the enhancer compared to the other population-specific alleles, suggesting enhancer variation as causative for decreased expression. We hypothesize that the selective forces present in East Asia favor reduced IVL expression; however, the precise nature of these forces is unknown. The IVL eQTLs that define the JPT/CHB haplotype and the other 923 IVL eQTLs fall within the boundaries of the three largest peaks for H3K27ac marks, suggesting that the actual enhancer boundary may not extend to the smaller, most 5' H3K27ac peak (Fig 3a) . Our data linking IVL eQTLs with AD further supports the emerging paradigm of previously-selected alleles that are now at a "mismatch" in the context of our current lifestyles and environment in the industrialized world 45 .
These findings motivate future studies to more closely examine IVL eQTLs (and other eQTLs in the EDC) as potential modifiers of penetrance and severity for FLG-LOF AD (Table S14 ).
Our discovery of enhancer variation for human skin barrier function further contributes to a growing body of research that highlights selective events in human history targeted at enhancers, such as lactase persistence [46] [47] [48] [49] [50] and immune function 51 . Furthermore, our finding for enhancer evolution further supports genetic innovation for human skin evolution that until now has been reported for only a few genes in the EDC, including IVL 52 . IVL has undergone extensive evolution in primates, with recent and continuing expansion of the number of repeats in human IVL [53] [54] [55] [56] [57] [58] [59] [60] [61] . However, targeted deletion of the Ivl gene in mice revealed no overt phenotype in barrier-housed conditions 62 , similar to our 923 del/del and 923 large/large homozygous mice (Fig. S1 ). Together this supports a tolerance for decreased, and even lack of, Ivl in barrierhoused conditions, consistent with human population-specific selection for differential IVL expression that warrants further investigation. The findings for a recent selective sweep for increased IVL in Northern latitudes suggests a possible link between cutaneous vitamin D production and IVL expression as a mechanism of environmental adaptation for the skin barrier.
Vitamin D is known to stimulate the differentiation of keratinocytes and promote the expression of CE genes, including IVL; it is possible that high rates of vitamin D deficiency in modern populations 63 could contribute to reduced skin barrier integrity and, subsequently, disease states.
In summary, our results highlight the significance of genetic variation attributed to differential gene expression in a population-specific manner and heighten our awareness for human population-specific evolution of the epidermis. Furthermore, our work provides a framework with which we can examine genetic variation in enhancer:target gene modules for recent adaptive traits. It also suggests a need for future studies to more closely examine variants associated with recently evolved traits as newly emerging disease risk variants during human transition to modernity. AL450992.1 RPTN FLG-AS1 LCE3E LCE2B LCE1C SPRR4 SPRR2G LOR S100A7A S100A2 S100A11 FLG-AS1 LCE3D LCE2A LCE1A SPRR1A PGLYRP3 S100A7 S100A16 500 kb hg19 152,500,000 153,000,000 153,500,000
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